Invesco Ltd. Pro Qr Therapeutics N.V. Transaction History

Invesco Ltd.

  • $557 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$1.33 - $2.77 $8,242 - $17,165
6,197 Added 52.13%
18,084 $24,000
Q4 2024

Feb 13, 2025
BUY
$1.81 - $4.49 $21,515 - $53,372
11,887 New
11,887 $32,000
Q3 2023

Nov 13, 2023
BUY
$1.3 - $1.77 $2,210 - $3,009
1,700 Added 8.89%
20,822 $27,000
Q2 2023

Aug 11, 2023
BUY
$1.62 - $2.32 $30,977 - $44,363
19,122 New
19,122 $30,000

Others Institutions Holding PRQR

# of Institutions
65
Shares Held
39.6M
Call Options Held
26K
Put Options Held
0
View Full List

About ProQR Therapeutics N.V.

PRQR Quotes by TradingView
  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $136M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email